Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about transcytosis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| amyloid-beta | regulates | protein | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TFRC | involved_in | gene | 0.90 |
| caveolin_1 | enhances | protein | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| LRP1-Mediated Transcytosis for CNS Antibody Delivery | 0.680 | neurodegeneration | Blood-brain barrier antibody transport m |
| LDLR Ligand-Binding Domain A Fusion for Receptor-Mediated Tr | 0.650 | neurodegeneration | Blood-brain barrier antibody transport m |
| Fusing IGFBPL1 to IGF-1 for Receptor-Mediated BBB Transcytos | 0.550 | drug delivery | Can IGFBPL1 therapeutics effectively cro |
| C1q-Targeted miR-33 ASO Delivery for APOE4 Hyper-Lipidation | 0.427 | molecular biology | Is APOE4's reduced lipid binding pathoge |
| C1q-Alectinib Complexation Facilitates Brain Penetration via | 0.145 | molecular biology | Does Alectinib truly bind C1q directly w |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.773
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning transcytosis in their description or question text
No additional research found